Impax Asset Management Group PLC Exact Sciences Corp Transaction History

Impax Asset Management Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	SELL	$59.06 - $75.72 $24,391 - $31,272	-413 Reduced 9.48%	3,945 $291,000
Q3 2023 Nov 07, 2023	BUY	$65.94 - $99.04 $50,905 - $76,458	772 Added 21.53%	4,358 $297,000
Q2 2023 Aug 07, 2023	SELL	$62.68 - $95.05 $3,071 - $4,657	-49 Reduced 1.35%	3,586 $336,000
Q1 2023 May 10, 2023	BUY	$47.19 - $70.77 $171,535 - $257,248	3,635 New	3,635 $246,000
Q2 2022 Aug 11, 2022	SELL	$35.61 - $76.23 $17,342 - $37,124	-487 Reduced 7.31%	6,171 $243,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $17,383 - $24,927	302 Added 4.75%	6,658 $466,000
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $460,810 - $639,922	6,356 New	6,356 $494,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

Stay updated on Impax Asset Management Group PLC with notifications on news.